Correlation Between Eupraxia Pharmaceuticals and Star Equity

Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Star Equity Holdings, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Star Equity.

Diversification Opportunities for Eupraxia Pharmaceuticals and Star Equity

0.47

Correlation Coefficient

Eupraxia Pharmaceuticals  Star Equity

Very weak diversification

The 3 months correlation between Eupraxia and Star is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Star Equity go up and down completely randomly.

Pair Corralation between Eupraxia Pharmaceuticals and Star Equity

Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to generate 2.09 times more return on investment than Star Equity. However, Eupraxia Pharmaceuticals is 2.09 times more volatile than Star Equity Holdings. It trades about 0.06 of its potential returns per unit of risk. Star Equity Holdings is currently generating about 0.09 per unit of risk. If you would invest  309.00  in Eupraxia Pharmaceuticals Common on December 29, 2024 and sell it today you would earn a total of  29.00  from holding Eupraxia Pharmaceuticals Common or generate 9.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Eupraxia Pharmaceuticals Commo  vs.  Star Equity Holdings

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Star Equity Holdings

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Star Equity Holdings are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Star Equity may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Eupraxia Pharmaceuticals and Star Equity

The main advantage of trading using opposite Eupraxia Pharmaceuticals and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.

The idea behind Eupraxia Pharmaceuticals Common and Star Equity Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.